Chemoinformaics analysis of Ursolic-Acid-Lactone
| Molecular Weight | 456.711 | nRot | 0 |
| Heavy Atom Molecular Weight | 408.327 | nRig | 30 |
| Exact Molecular Weight | 456.36 | nRing | 6 |
| Solubility: LogS | -5.735 | nHRing | 1 |
| Solubility: LogP | 5.762 | No. of Aliphatic Rings | 6 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
| Atoms Count | 81 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 33 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 5 |
| No. of Hydrogen atom | 48 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 30 | No. of Saturated Rings | 6 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 84.5121 |
| nHD | 1 | BPOL | 50.7579 |
| QED | 0.409 |
| Synth | 6.233 |
| Natural Product Likeliness | 3.154 |
| NR-PPAR-gamma | 0.074 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.696 |
| Pgp-sub | 0 |
| HIA | 0.01 |
| CACO-2 | -5.111 |
| MDCK | 0.0000215 |
| BBB | 0.461 |
| PPB | 0.991815 |
| VDSS | 1.275 |
| FU | 0.0240838 |
| CYP1A2-inh | 0.011 |
| CYP1A2-sub | 0.49 |
| CYP2c19-inh | 0.056 |
| CYP2c19-sub | 0.954 |
| CYP2c9-inh | 0.113 |
| CYP2c9-sub | 0.108 |
| CYP2d6-inh | 0.018 |
| CYP2d6-sub | 0.624 |
| CYP3a4-inh | 0.288 |
| CYP3a4-sub | 0.585 |
| CL | 19.586 |
| T12 | 0.011 |
| hERG | 0.024 |
| Ames | 0.022 |
| ROA | 0.317 |
| SkinSen | 0.111 |
| Carcinogencity | 0.02 |
| EI | 0.125 |
| Respiratory | 0.955 |
| NR-Aromatase | 0.746 |
| Antiviral | No |
| Prediction | 0.718907 |